Aperture Investors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.59M Sell
70,439
-28,682
-29% -$1.36M 0.33% 63
2025
Q4
$5.04M Hold
99,121
0.7% 44
2025
Q3
$5.5M Buy
99,121
+35,317
+55% +$2.07M 0.76% 37
2025
Q2
$4.4M Hold
63,804
0.59% 51
2025
Q1
$4.43M Buy
63,804
+9,344
+17% +$772K 0.67% 51
2024
Q4
$4.68M Hold
54,460
0.61% 47
2024
Q3
$6.48M Hold
54,460
0.82% 35
2024
Q2
$7.77M Hold
54,460
1.14% 31
2024
Q1
$6.99M Buy
54,460
+22,842
+72% +$2.72M 0.9% 40
2023
Q4
$3.27M Sell
31,618
-30,534
-49% -$3.02M 0.58% 46
2023
Q3
$5.65M Sell
62,152
-4,788
-7% -$422K 0.9% 35
2023
Q2
$5.42M Hold
66,940
0.67% 43
2023
Q1
$5.33M Buy
66,940
+10,208
+18% +$724K 0.75% 38
2022
Q4
$3.84M Sell
56,732
-22,050
-28% -$1.29M 0.63% 40
2022
Q3
$3.92M Buy
78,782
+53,410
+211% +$2.86M 0.64% 41
2022
Q2
$1.41M Buy
+25,372
New +$1.41M 0.24% 55

Other funds holding NVO